2.0
Jul 26, 2012
Anonymous employee
Current employee, more than 5 years
Wilmington, DE
Recommend
CEO approval
Business outlook
Pros
Generous compensation and benefits, nice facilities, business-casual attire.
Cons
Successive rounds of layoffs offset only by new positions in China; recent product failures and weak pipeline including at MedImmune biotech arm; current near-ban on travel, relocations, hiring from the outside and use of outside consultants; timid, risk-averse management; in-bred, protect-each-other culture at the C-suite level.